azelastine has been researched along with interleukin-8 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horie, T; Kikuchi, H; Ohkuma, A; Ohtsuka, A; Okayasu, M; Yoshizawa, T | 1 |
| Kato, I; Osaki, T; Ueta, E; Yamamoto, T; Yoneda, K | 1 |
| Athanassiou, A; Basu, S; Boucher, W; Huang, M; Kandere-Grzybowska, K; Kempuraj, D; Letourneau, R; Theoharides, TC | 1 |
| Bachert, C; Baumann, D; Högger, P | 1 |
1 trial(s) available for azelastine and interleukin-8
| Article | Year |
|---|---|
A clinical trial of Azelastine in recurrent aphthous ulceration, with an analysis of its actions on leukocytes.
Topics: Adolescent; Adult; Aged; Cell Survival; Child; Erythrocytes; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukin-1; Interleukin-8; Leukocytes; Leukocytes, Mononuclear; Lipoxygenase Inhibitors; Luminescent Measurements; Male; Middle Aged; Neutrophils; Oxides; Phthalazines; Recurrence; Stomatitis, Aphthous; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1994 |
3 other study(ies) available for azelastine and interleukin-8
| Article | Year |
|---|---|
[Role of plasma histamine and neutrophil chemotactic factor in exercise-induced asthma].
Topics: Adolescent; Adult; Asthma; Asthma, Exercise-Induced; Chemotactic Factors; Female; Histamine; Histamine H1 Antagonists; Humans; Interleukin-8; Male; Middle Aged; Phthalazines | 1989 |
Azelastine inhibits secretion of IL-6, TNF-alpha and IL-8 as well as NF-kappaB activation and intracellular calcium ion levels in normal human mast cells.
Topics: Calcium; Cells, Cultured; Histamine H1 Antagonists; Humans; Interleukin-6; Interleukin-8; Mast Cells; NF-kappa B; Phthalazines; Tumor Necrosis Factor-alpha | 2003 |
Development of a novel model for comparative evaluation of intranasal pharmacokinetics and effects of anti-allergic nasal sprays.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Administration, Inhalation; Administration, Intranasal; Aerosols; Androstadienes; Anti-Allergic Agents; Anti-Inflammatory Agents; Budesonide; Cell Line, Tumor; Delayed-Action Preparations; Epithelial Cells; Fluticasone; Glucocorticoids; Histamine Antagonists; Humans; Interleukin-8; Lung; Lung Neoplasms; Mucociliary Clearance; Nasal Lavage Fluid; Nasal Sprays; Phthalazines; Rhinitis, Allergic, Seasonal | 2012 |